Cargando…
NLRP3 inflammasome as a novel therapeutic target for heart failure
Heart failure (HF) is a leading cause of mortality worldwide. The pathogenesis of HF is complex and has not yet been fully elucidated, which has slowed drug development and long-term treatments. Inflammasome-mediated responses occur during the progression of HF. It has been reported that energy meta...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish Society of Cardiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878950/ https://www.ncbi.nlm.nih.gov/pubmed/35191381 http://dx.doi.org/10.5152/AnatolJCardiol.2021.580 |